- Home
- PLBC vs GOSS Comparison
PLBC vs GOSS Comparison
Compare PLBC & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBC
- GOSS
- Stock Information
- Founded
- PLBC 1980
- GOSS 2015
- Country
- PLBC United States
- GOSS United States
- Employees
- PLBC N/A
- GOSS N/A
- Industry
- PLBC Finance Companies
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- PLBC Finance
- GOSS Health Care
- Exchange
- PLBC Nasdaq
- GOSS Nasdaq
- Market Cap
- PLBC 253.9M
- GOSS 212.9M
- IPO Year
- PLBC 2005
- GOSS 2019
- Fundamental
- Price
- PLBC $48.65
- GOSS $0.81
- Analyst Decision
- PLBC Buy
- GOSS Strong Buy
- Analyst Count
- PLBC 2
- GOSS 5
- Target Price
- PLBC $52.50
- GOSS $9.20
- AVG Volume (30 Days)
- PLBC 8.8K
- GOSS 2.3M
- Earning Date
- PLBC 01-15-2025
- GOSS 11-07-2024
- Dividend Yield
- PLBC 2.30%
- GOSS N/A
- EPS Growth
- PLBC N/A
- GOSS N/A
- EPS
- PLBC 4.77
- GOSS N/A
- Revenue
- PLBC $79,873,000.00
- GOSS $105,322,000.00
- Revenue This Year
- PLBC N/A
- GOSS N/A
- Revenue Next Year
- PLBC $15.50
- GOSS N/A
- P/E Ratio
- PLBC $9.84
- GOSS N/A
- Revenue Growth
- PLBC 3.64
- GOSS N/A
- 52 Week Low
- PLBC $32.50
- GOSS $0.50
- 52 Week High
- PLBC $51.33
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- PLBC 55.49
- GOSS 49.87
- Support Level
- PLBC $47.68
- GOSS $0.76
- Resistance Level
- PLBC $49.27
- GOSS $0.88
- Average True Range (ATR)
- PLBC 1.22
- GOSS 0.08
- MACD
- PLBC -0.44
- GOSS 0.01
- Stochastic Oscillator
- PLBC 65.45
- GOSS 30.48
About PLBC Plumas Bancorp
Plumas Bancorp is a bank holding company that provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.